Required therapeutic dose of 131I for thyroid ablation after surgery for differentiated thyroid carcinoma

被引：0
|
作者：
Yaneva, M. [1 ]
Botushanova, A. [1 ]
机构：
[1] UMBAL St George Plovdiv, Plovdiv, Bulgaria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2013年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S399 / S399
页数：1
相关论文
共 50 条
  • [11] Changes of dose equivalent rate in vitro in patients with differentiated thyroid carcinoma after 131I remnant ablation after injection of rHTSH
    Wu, Yuping
    Zhang, Xiaoyu
    Lu, Keyi
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [12] 131I BIOKINETICS AND CYTOGENETIC DOSE ESTIMATES IN ABLATION TREATMENT OF THYROID CARCINOMA
    Nascimento, Ana C. H.
    Lipsztein, Joyce L.
    Corbo, Rossana
    Rebelo, Ana M. O.
    HEALTH PHYSICS, 2010, 99 (04): : 457 - 463
  • [13] INADEQUACY OF MODERATE DOSE OF I-131 FOR ABLATION OF THYROID REMNANTS FOLLOWING SURGERY FOR DIFFERENTIATED THYROID-CARCINOMA (DTC)
    SIDDIQUI, AR
    EDMONDSON, J
    WELLMAN, HN
    PARK, HM
    SCHNUTE, R
    JOHNSTON, CC
    JOURNAL OF NUCLEAR MEDICINE, 1980, 21 (06) : P30 - P30
  • [14] Optimization of 131I activity value required for thyroid remnants and metastatic lesions ablation in children with differentiated thyroid cancer
    Kozak, OV
    Shishkina, VV
    Korchinskaya, OL
    Sagan, DL
    Dzhuza, DA
    Trocevskiy, VV
    EXPERIMENTAL ONCOLOGY, 2003, 25 (03) : 221 - 224
  • [15] Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma
    Verburg, Frederik A.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 253 - 257
  • [16] The evolving role of 131I for the treatment of differentiated thyroid carcinoma
    Robbins, RJ
    Schlumberger, MJ
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 : 28S - 37S
  • [17] Prognostic Value of Thyroglobulin Levels and Therapeutic 131I Whole-Body Scan after Initial 131I Ablation of Differentiated Thyroid Cancer
    Luo, Q.
    Yu, Y.
    Lu, H.
    Zhu, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S241 - S241
  • [18] Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer
    Gortan, Fatma Arzu
    Yuksel, Alptug Ozer
    Gulaldi, Nedim Cuneyt Murat
    Coskun, Nazim
    Akca, Ceren Deniz Kapulu
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 260 - 268
  • [19] Implications of mediastinal uptake of 131I with regard to surgery in patients with differentiated thyroid carcinoma
    Haveman, JW
    Phan, HTT
    Links, TP
    Jager, PL
    Plukker, JTM
    CANCER, 2005, 103 (01) : 59 - 67
  • [20] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Jin, Pingyan
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Sun, Yungang
    Xian, Jialang
    Huang, Liuhua
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2018, 57 (02) : 169 - 177
12345